Bringing the fundamentals into focus…
Back to TG Therapeutics, Inc.
How TG Therapeutics, Inc. stacks up
TGTX · against 177 other Healthcare companies of similar size
Valuation
55/ 100
Above the middle of the pack.
Ranked #80 of 178 · scores higher than 53% of peers
Bars: peers in each 10-point band of the valuation score28 peers with a valuation score of 50–59, including TGTX · Click a bar to see the companies
Why valuation scores 55?
Weighted metrics compared with all Healthcare companies.A mix: stronger earnings yield, but weaker EBITDA yield than most Healthcare peers.
- less operating profit (EBITDA) for the company's total value: weaker than 63% of peers. EBITDA yield: 1.4% vs peer median 4.0%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 0.2% vs peer median 0.0%
- higher earnings for the price paid: stronger than 75% of peers. Earnings yield: 4.7% vs peer median 1.5%
Metric by metric
Position: dot = TGTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | TGTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 177 reported | 4.5% | 2.6% | 81% | 30% | |
| EBITDA yieldHigher is better · 177 reported | 1.5% | 4.7% | 26% | 50% | |
| Free cash flow yieldHigher is better · 106 reported | 0.2% | 2.2% | 34% | 20% | |
| Book yieldHigher is better · 176 reported | 6.8% | 19.6% | 17% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around TGTX| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 80 | 548.2B INR (≈$6.6B) | 55 | 68 | |
| 80 | 414.8B INR (≈$5.0B) | 55 | 73 | |
| 80 | 1.13T INR (≈$13.5B) | 55 | 61 | |
| 80 | 494.7B INR (≈$5.9B) | 55 | 70 | |
| 80 | 9.3B USD | 55 | 64 | |
| 85 | 5.8B USD | 54 | 68 | |
| 85 | 166.5B SEK (≈$16.6B) | 54 | 49 | |
| 85 | 16.1B CHF (≈$18.5B) | 54 | 54 | |
| 88 | 13.8B USD | 53 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score